Skip to main content

Table 2 Emergence agitation and VAS score

From: “The effect of intramuscular dexmedetomidine versus oral gabapentin premedication on the emergence agitation after rhinoplasty”. A prospective, randomized, double-blind controlled trial

 

C

D

G

P value

EA

5 (3–7)

4 (2–5)

4 (2–6)

0.002

Incidence of EA(n = 51)

29(56.9%)

9(17.6%)

21(41.2%)

< 0.001*

Postoperative pethidine consumption(mg)

93.7 ± 12

33.14 ± 18.6

40.5 ± 21.5

< 0.001#

Midazolam(mg)

1.5(0–4)

0(0–4)

0(0–4)

0.01

VAS 4 h

4 (3–6)

2 (1–3)

2 (1–3)

< 0.001

VAS 8 h

4 (3–5)

2 (1–3)

2 (1–4)

< 0.001

VAS 12 h

4 (3–5)

3 (2–4)

3 (2–4)

< 0.001

Pairwise comparisons

 

D-G

D-C

G-C

EA

0.006

< 0.001

0.023

Postoperative pethidine consumption#

0.117

< 0.001

< 0.001

Midazolam

0.439

0.003

0.03

VAS 4 h

0.413

< 0.001

< 0.001

VAS 8 h

0.306

< 0.001

< 0.001

VAS 12 h

0.391

< 0.001

< 0.001

  1. Data expressed as median (range), mean ± SD, frequency (percentage). p value = Kruskal-Wallis test, *= chi square test, #= one way ANOVA
  2. P < 0.05 is considered statistically significant